- Home
- STTK vs BRFH Comparison
STTK vs BRFH Comparison
Compare STTK & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- BRFH
- Stock Information
- Founded
- STTK 2016
- BRFH 2005
- Country
- STTK United States
- BRFH United States
- Employees
- STTK N/A
- BRFH N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- BRFH Packaged Foods
- Sector
- STTK Health Care
- BRFH Consumer Staples
- Exchange
- STTK Nasdaq
- BRFH Nasdaq
- Market Cap
- STTK 56.8M
- BRFH 50.9M
- IPO Year
- STTK 2020
- BRFH N/A
- Fundamental
- Price
- STTK $1.37
- BRFH $4.42
- Analyst Decision
- STTK Hold
- BRFH Strong Buy
- Analyst Count
- STTK 3
- BRFH 1
- Target Price
- STTK $2.00
- BRFH $4.50
- AVG Volume (30 Days)
- STTK 131.9K
- BRFH 10.9K
- Earning Date
- STTK 03-03-2025
- BRFH 02-27-2025
- Dividend Yield
- STTK N/A
- BRFH N/A
- EPS Growth
- STTK N/A
- BRFH N/A
- EPS
- STTK N/A
- BRFH N/A
- Revenue
- STTK $6,435,000.00
- BRFH $9,851,000.00
- Revenue This Year
- STTK $313.04
- BRFH $51.72
- Revenue Next Year
- STTK N/A
- BRFH $38.85
- P/E Ratio
- STTK N/A
- BRFH N/A
- Revenue Growth
- STTK 382.75
- BRFH 29.01
- 52 Week Low
- STTK $0.94
- BRFH $1.00
- 52 Week High
- STTK $11.76
- BRFH $4.61
- Technical
- Relative Strength Index (RSI)
- STTK 60.23
- BRFH 69.87
- Support Level
- STTK $1.21
- BRFH $3.44
- Resistance Level
- STTK $1.36
- BRFH $3.95
- Average True Range (ATR)
- STTK 0.10
- BRFH 0.25
- MACD
- STTK 0.01
- BRFH 0.08
- Stochastic Oscillator
- STTK 90.00
- BRFH 86.57
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.